Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD76m

    Last close

    USD0.81

    ▲ 0.00 (0.12%)

    Canyon Resources

    MCap

    AUD262m

    Last close

    AUD0.19

    ▲ 0.02 (12.12%)

    Immix Biopharma

    MCap

    USD51m

    Last close

    USD1.82

    ▲ 0.12 (7.06%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Plant Health Care – executive interview

Plant Health Care – executive interview

In this video, Dr Chris Richards, Plant Health Care’s CEO, discusses FY19 performance. He comments on the status of PREtec peptide commercialisation and the impact that the COVID-19 pandemic has had on the business, noting that there has been little impact on production so far, although demand for some crop applications has been affected. He describes how he sees revenues and profitability developing once the lockdowns have eased and concludes with some remarks on the relationship with recent investor, Ospraie Ag Science.

Plant Health Care provides innovative proprietary agricultural biological products to the global agricultural market. These focus on improving crop performance, strengthening a plant’s resistance to soil pests or drought and increasing yield.

< Previous
Next >

You may also be interested in these:

Healthcare

Recce Pharmaceuticals – executive interview

TMT

VEON – executive interview with CFO Joop Brakenhoff

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free